Man Shu
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 10
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
-
- Nanoplatforms for cancer theranostics 4
- Graphene and Nanomaterials Applications 2
- Co-authors
- Jie Liu (4 shared papers)Zhaozhong Jiang (4 shared papers)Qiang Zeng (3 shared papers)Lili Chen (2 shared papers)Ling Xue (4 shared papers)Chao Li (1 shared paper)Junjie Tang (1 shared paper)Zhiyong Guo (1 shared paper)
- Journals
- BMC Cancer (2 papers)British Journal of Cancer (1 paper)Materials Science and Engineering C (1 paper)Journal of Materials Chemistry B (1 paper)Bioactive Materials (1 paper)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Man Shu
21 papers receiving 414 citations
Peers
Comparison fields: 5 of 69
- Biomaterials 99
- Hepatology 60
- Cancer Research 86
- Oncology 145
- Pulmonary and Respiratory Medicine 93
Countries citing papers authored by Man Shu
This map shows the geographic impact of Man Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Shu more than expected).
Fields of papers citing papers by Man Shu
This network shows the impact of papers produced by Man Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Shu. The network helps show where Man Shu may publish in the future.
Co-authors
The 25 scholars most cited alongside Man Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 95 | |
| 2 | 2016 | 95 | |
| 3 | 2016 | 32 | |
| 4 | 2015 | 29 | |
| 5 | 2020 | 27 | |
| 6 | 2018 | 24 | |
| 7 | 2018 | 21 | |
| 8 | 2021 | 14 | |
| 9 | 2019 | 14 | |
| 10 | 2022 | 12 | |
| 11 | 2020 | 11 | |
| 12 | 2024 | 9 | |
| 13 | 2018 | 8 | |
| 14 | 2023 | 7 | |
| 15 | 2018 | 7 | |
| 16 | 2019 | 6 | |
| 17 | 2023 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2024 | 1 |
About Man Shu
Man Shu is a scholar working on Oncology, Biomedical Engineering, Surgery, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 418 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer Cells and Metastasis (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Genomics and Diagnostics (2 papers), Graphene and Nanomaterials Applications (2 papers) and Gallbladder and Bile Duct Disorders (2 papers). The work is most often cited by research in Biomaterials (99 citations), Hepatology (60 citations), Cancer Research (86 citations), Oncology (145 citations) and Pulmonary and Respiratory Medicine (93 citations). Man Shu has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Jie Liu, Zhaozhong Jiang, Qiang Zeng, Lili Chen, Ling Xue, Chao Li, Junjie Tang, Zhiyong Guo, Baogang Peng and Shunjun Fu. Their work appears in journals such as BMC Cancer, British Journal of Cancer, Materials Science and Engineering C, Journal of Materials Chemistry B and Bioactive Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.